SB-297006

N/A

Report date: 2025/03/18 15:07:36
NME

Base Information

Drug NameSB-297006
Drug Alias NameSB-297006
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 3 antagonists
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A